Literature DB >> 303143

Immunologic characterization of chronic lymphocytic leukemia cells.

T L Whiteside, A Winkelstein, B S Rabin.   

Abstract

Immunologic characterization of the neoplastic cells in the circulation of patients with CLL suggests these cells show significant differences in membrane characteristics from normal B lymphocytes. Although the leukemic cells bear a homogenous membrane-associated immunoglobulin, they also react with an anti-human T cell serum. In all patients studied, 60-90% of the cells, were stained by this antiserum. This suggests that the leukemic cells share antigenic determinants with T lymphocytes. CLL cells, unlike normal B cells, showed a marked increase in mouse-complement receptors. No increase in receptors for guinea pig complement was observed in the leukemic cells. The population of SIg-bearing lymphocytes was significantly greater than that of complement-receptor bearing lymphocytes. The total number of E-rosetting cells was increased in all CLL patients. Mitogenic responses of the leukemic cells were depressed and delayed. These results suggest that neoplastic lymphocytes cannot be classified as T- or B-derived on the basis of criteria used to define normal lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 303143     DOI: 10.1002/1097-0142(197703)39:3<1109::aid-cncr2820390316>3.0.co;2-b

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

Review 1.  Immune deficiencies in chronic lymphocytic leukemia and multiple myeloma.

Authors:  A Winkelstein; P S Jordan
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer

2.  T-cell and B-cell identification in the diagnosis of lymphoproliferative disease. A review.

Authors:  T L Whiteside; D T Rowlands
Journal:  Am J Pathol       Date:  1977-09       Impact factor: 4.307

3.  Flow cytometric analysis of T-lymphocyte subpopulations in B-cell chronic lymphocytic leukemia: correlation with clinical stage.

Authors:  M L Hautekeete; R F De Bock; D R Van Bockstaele; G C Colpin; Z N Berneman; M E Peetermans
Journal:  Blut       Date:  1987-11

4.  Further evidence for T cell abnormalities in chronic lymphocytic leukaemia of the B cell type.

Authors:  F Herrmann; G Sieber; Z Chen; B Enders; B Komischke; H Rühl
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

5.  Quantification of newly produced B and T lymphocytes in untreated chronic lymphocytic leukemia patients.

Authors:  Marina Motta; Marco Chiarini; Claudia Ghidini; Cinzia Zanotti; Cinzia Lamorgese; Luigi Caimi; Giuseppe Rossi; Luisa Imberti
Journal:  J Transl Med       Date:  2010-11-05       Impact factor: 5.531

6.  A new human T-cell differentiation antigen: unexpected expression on chronic lymphocytic leukemia cells.

Authors:  P J Martin; J A Hansen; R C Nowinski; M A Brown
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

7.  Dissection of distinct human immunoregulatory T-cell subsets by a monoclonal antibody recognizing a cell surface antigen with wide tissue distribution.

Authors:  O H Irigoyen; P V Rizzolo; Y Thomas; M E Hemler; H H Shen; S M Friedman; J L Strominger; L Chess
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

8.  High and low Fc IgG-receptor expression in human chronic granulocytic leukaemia cells.

Authors:  A Harłozińska; J Potomski; B Lawinska; A Noworolska; R Richter
Journal:  Br J Cancer       Date:  1982-02       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.